Commentary: the impact of Covid‐19 on psychopathology in children and young people worldwide – reflections on Newlove‐Delgado et al. (2023)
Commentary: the impact of Covid‐19 on psychopathology in children and young people worldwide – reflections on Newlove‐Delgado et al. (2023)
In the past 3 years, since the beginning of the Covid-19 pandemic, there has been an impressive flourishing body of publications on the impact of the pandemic and related restrictions on the mental health of children and young people. It was about time for a rigorous quantitative evidence synthesis of this large body of research. Newlove-Delgado et al. (J Child Psychol Psychiatry, 2022) took on this challenge by completing a systematic review with meta-analysis of epidemiological studies on the impact of Covid-19 on psychopathology in children and adolescents, featured in the 2023 Annual Research Review series of the Journal. Overall, this meta-analysis shows that the relationship between mental health and Covid-19 pandemic in children and adolescents is complex and, as such, it ought to be addressed by studies using rigorous methods and advanced analytic strategies. Collectively, as a field, we should and could do better with regards to the scope and quality of the studies in this area.
641-644
Cortese, Samuele
53d4bf2c-4e0e-4c77-9385-218350560fdb
Solmi, Marco
256504f2-483a-4b42-bfab-081c6a617867
Correll, Christoph U.
d1a6c4a7-3911-4ffb-9d9d-4d70f6b574b1
Cortese, Samuele
53d4bf2c-4e0e-4c77-9385-218350560fdb
Solmi, Marco
256504f2-483a-4b42-bfab-081c6a617867
Correll, Christoph U.
d1a6c4a7-3911-4ffb-9d9d-4d70f6b574b1
Cortese, Samuele, Solmi, Marco and Correll, Christoph U.
(2023)
Commentary: the impact of Covid‐19 on psychopathology in children and young people worldwide – reflections on Newlove‐Delgado et al. (2023).
Journal of Child Psychology and Psychiatry, 64 (4), .
(doi:10.1111/jcpp.13765).
Abstract
In the past 3 years, since the beginning of the Covid-19 pandemic, there has been an impressive flourishing body of publications on the impact of the pandemic and related restrictions on the mental health of children and young people. It was about time for a rigorous quantitative evidence synthesis of this large body of research. Newlove-Delgado et al. (J Child Psychol Psychiatry, 2022) took on this challenge by completing a systematic review with meta-analysis of epidemiological studies on the impact of Covid-19 on psychopathology in children and adolescents, featured in the 2023 Annual Research Review series of the Journal. Overall, this meta-analysis shows that the relationship between mental health and Covid-19 pandemic in children and adolescents is complex and, as such, it ought to be addressed by studies using rigorous methods and advanced analytic strategies. Collectively, as a field, we should and could do better with regards to the scope and quality of the studies in this area.
Text
Cortese_Solmi_Correll_JCPP_submission
- Accepted Manuscript
More information
Accepted/In Press date: 26 January 2023
e-pub ahead of print date: 13 March 2023
Additional Information:
Funding Information:
S.C. has received honoraria from the following non‐profit associations: British Association for Psychopharmacology (BAP), Association for Child and Adolescent mental health (ACAMH), and Canadian ADHD Alliance Resource (CADDRA). M.S. received honoraria/has been consultant for Angelini, Lundbeck. C.C. has been a consultant and/or advisor to or has received honoraria from: AbbVie, Acadia, Alkermes, Allergan, Angelini, Aristo, Boehringer‐Ingelheim, Cardio Diagnostics, Cerevel, CNX Therapeutics, Compass Pathways, Darnitsa, Gedeon Richter, Hikma, Holmusk, IntraCellular Therapies, Janssen/J&J, Karuna, LB Pharma, Lundbeck, MedAvante‐ProPhase, MedInCell, Merck, Mindpax, Mitsubishi Tanabe Pharma, Mylan, Neurocrine, Newron, Noven, Novo Nordisk, Otsuka, Pharmabrain, PPD Biotech, Recordati, Relmada, Reviva, Rovi, Seqirus, SK Life Science, Sunovion, Sun Pharma, Supernus, Takeda, Teva, and Viatris. He provided expert testimony for Janssen and Otsuka. He served on a Data Safety Monitoring Board for Compass, Lundbeck, Relmada, Reviva, Rovi, Supernus, and Teva. He has received grant support from Janssen and Takeda. He received royalties from UpToDate and is also a stock option holder of Cardio Diagnostics, Mindpax, LB Pharma and Quantic.
Identifiers
Local EPrints ID: 477268
URI: http://eprints.soton.ac.uk/id/eprint/477268
ISSN: 1469-7610
PURE UUID: 28e5dbd5-ed18-4b7d-a090-cde8d21d7262
Catalogue record
Date deposited: 01 Jun 2023 17:06
Last modified: 17 Mar 2024 07:43
Export record
Altmetrics
Contributors
Author:
Marco Solmi
Author:
Christoph U. Correll
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics
